Article by Andrew Jack in Financial Times (15 December 2009)
Nine western pharmaceutical companies face fresh pressure to ease control over their HIV medicines following the establishment of an international mechanism designed to increase treatment access in the developing world.
The board of Unitaid, the French-backed health funding agency, voted on Tuesday to create a “patent pool” [...]
UNITAID EXECUTIVE BOARD APPROVES BREAKTHROUGH PLAN TO MAKE AIDS TREATMENT MORE WIDELY AVAILABLE AT LOWER COST
PATENT POOL COULD SAVE OVER ONE BILLION DOLLARS A YEAR
Geneva, 14 December 2009 — Today UNITAID’s Executive Board made a landmark decision to establish a Patent Pool for AIDS medicines. The pool, scheduled to start operating in mid-2010, aims to [...]
Ce 13 février, Andrew Witty, PDG de GlaxoSmithKline, a appelé à la création d’un fonds commun de brevets basé sur le volontariat pour le développement de nouveaux traitements pour les maladies négligées dans les pays émergents, et annoncé qu’il réduira le prix des médicaments sous brevet qu’il vend dans les pays les plus pauvres.
UNITAID Statement [...]
